SUVRETTA CAPITAL MANAGEMENT, LLC - POINT BIOPHARMA GLOBAL INC ownership

POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 35 filers reported holding POINT BIOPHARMA GLOBAL INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
SUVRETTA CAPITAL MANAGEMENT, LLC ownership history of POINT BIOPHARMA GLOBAL INC
ValueSharesWeighting
Q4 2022$19,150,830
+6.3%
2,627,000
+12.7%
0.80%
+7.5%
Q3 2022$18,018,000
-12.2%
2,330,902
-22.7%
0.75%
-4.2%
Q2 2022$20,528,000
-14.6%
3,014,4080.0%0.78%
+6.4%
Q1 2022$24,025,000
+60.5%
3,014,408
+12.8%
0.73%
+153.1%
Q4 2021$14,968,000
-12.5%
2,672,863
+20.1%
0.29%
+0.7%
Q3 2021$17,110,0002,225,0000.29%
Other shareholders
POINT BIOPHARMA GLOBAL INC shareholders Q3 2021
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,312,523$18,431,0004.36%
GREAT POINT PARTNERS LLC 2,060,000$16,418,0003.97%
RA Capital Management 9,003,018$71,754,0001.57%
JOHNSON & JOHNSON 1,000,000$7,970,0001.51%
BVF INC/IL 3,367,826$26,842,0001.07%
Boxer Capital, LLC 2,500,000$19,925,0001.02%
Sio Capital Management, LLC 377,684$3,010,0001.00%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,014,408$24,025,0000.73%
SILVERARC CAPITAL MANAGEMENT, LLC 204,679$1,631,0000.68%
Atom Investors LP 60,103$479,0000.22%
View complete list of POINT BIOPHARMA GLOBAL INC shareholders